NLK and hepatocellular carcinoma: However, although NLK was revealed to be overexpressed in hepatocellular carcinomas, depletion of NLK reduced cell growth, and did so by inhibiting the expression of cyclinD1 and CDK2, both essential for the mitogenic potential of tumor cells [28].